Inventor · disambiguated record
Leonard W. Rozamus
Also filed as: ROZAMUS JR LEONARD WALTER · ROZAMUS LEONARD · ROZAMUS LEONARD W
25 granted patents·12 pending applications·575 citations·filing 1993–2023
96Inventor score
Files withARIAD PHARMA INC15ARIAD GENE THERAPEUTICS INC7TAKEDA PHARMACEUTICALS CO4SMITHKLINE BEECHAM CORP3BERSTEIN DAVID L2
Top patents by PatentIndex Score
37 records- 0197US7091213B2Phosphorus-containing compounds and uses thereofARIAD GENE THERAPEUTICS INC·Filed 2004·Granted Aug 15, 2006·150 cites·36 claims
- 0297US6649595B2Regulation of biological events using novel compoundsARIAD GENE THERAPEUTICS INC·Filed 2001·Granted Nov 18, 2003·122 cites·36 claims
- 0395US9493470B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl) methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2013·Granted Nov 15, 2016·16 cites·17 claims
- 0494US6693189B2Materials and method for treating or preventing pathogenic fungal infectionARIAD GENE THERAPEUTICS INC·Filed 2001·Granted Feb 17, 2004·43 cites·9 claims
- 0594US6187757B1Regulation of biological events using novel compoundsARIAD GENE THERAPEUTICS INC·Filed 1998·Granted Feb 13, 2001·127 cites·54 claims
- 0690US7186826B2Phosphorus-containing compounds and uses thereofARIAD GENE THERAPEUTICS INC·Filed 2006·Granted Mar 6, 2007·10 cites·4 claims
- 0790US6258823B1Materials and method for treating or preventing pathogenic fungal infectionARIAD GENE THERAPEUTICS INC·Filed 1997·Granted Jul 10, 2001·47 cites·40 claims
- 0889US10125136B2Crystalline forms of 3-(imidazo[1,2-B] pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 0988US10662197B2Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2018·Granted May 26, 2020·4 cites·11 claims
- 1084US2024083902A1Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2023·Application pending·0 cites
- 1184US2024043457A1Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4[(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1280US7709020B2Implantable device comprising phosphorus-containing macrolidesARIAD PHARMA INC·Filed 2007·Granted May 4, 2010·2 cites·4 claims
- 1379US11192896B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·18 claims
- 1478US11192895B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·24 claims
- 1578US11192897B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Dec 7, 2021·0 cites·23 claims
- 1678US2024082275A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1777US11384086B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1- yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2021·Granted Jul 12, 2022·0 cites·19 claims
- 1876USRE37421ERapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Oct 23, 2001·16 cites·20 claims
- 1974US11279705B2Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide and its mono hydrochloride saltARIAD PHARMA INC·Filed 2020·Granted Mar 22, 2022·0 cites·3 claims
- 2072US11427605B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2020·Granted Aug 30, 2022·0 cites·8 claims
- 2171US8058426B2Phosphorus-containing compounds and uses thereofBERSTEIN DAVID L·Filed 2010·Granted Nov 15, 2011·1 cites·7 claims
- 2271US2022249524A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2370US9024014B2Phosphorus-containing compounds and uses thereofBERSTEIN DAVID L·Filed 2011·Granted May 5, 2015·1 cites·25 claims
- 2469US2021401860A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2568US5648361ARapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Jul 15, 1997·22 cites·18 claims
- 2666US10934317B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl) phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] phenyl} pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2019·Granted Mar 2, 2021·0 cites·13 claims
- 2766US2021186994A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2021·Application pending·0 cites
- 2862US2004082515A1Regulation of biological events using novel compoundsARIAD GENE THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 2956US10385078B2Crystalline forms of 5-chloro-N4-[-2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-YL) piperidin-1-YL]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2015·Granted Aug 20, 2019·0 cites·8 claims
- 3056US5661156ARapamycin derivativesSMITHKLINE BEECHAM CORP·Filed 1993·Granted Aug 26, 1997·11 cites·17 claims
- 3156US2005026868A1Phosphorus-containing macrocyclesFiled 2004·Application pending·0 cites
- 3256US2004073024A1Phosphorus-containing compounds and uses thereofFiled 2003·Application pending·0 cites
- 3355US2003220297A1Phosphorus-containing compounds and uses thereofFiled 2003·Application pending·0 cites
- 3455US2018256610A1Pharmaceutical formulations comprising 5-Chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamineARIAD PHARMA INC·Filed 2018·Application pending·0 cites
- 3551US2006247265A1Therapies for treating disorders of the eyeCLACKSON TIMOTHY P·Filed 2005·Application pending·0 cites
- 3650US11767319B2Crystalline forms of a selective c-kit kinase inhibitorTHIRD HARMONIC BIO INC·Filed 2021·Granted Sep 26, 2023·0 cites·24 claims
- 3746US7432277B2Phosphorus-containing macrocyclesARAID GENE THERAPEUTICS INC·Filed 2006·Granted Oct 7, 2008·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →